Näytetään tulokset 1 - 10 / 39
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi
 Julkaisujen tiedon ikoni

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML:the HOVON-SAKK-132 trial

Vertaisarvioitu
Avoin saatavuus
DOI
10.1182/bloodadvances.2020003855
Dutch-Belgian Hemato-Oncology Coop; Swiss Grp Clinical Canc Res SAKK; Löwenberg, Bob; Pabst, Thomas;...
Blood advances2021 Julkaisujen tiedon ikoni

RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/s00277-019-03815-7
Sini Luoma, Pekka Anttila, Marjaana Säily, Tuija Lundan, Jouni Heiskanen, Timo Siitonen, Sakari Kakk...
Annals of hematology2019 Julkaisujen tiedon ikoni

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy

Vertaisarvioitu
Luoma S; Sergeev P; Javarappa KK; Öhman TJ; Varjosalo M; Säily M; Anttila P; Sankelo M; Partanen A; ...
Cancers2023 Julkaisujen tiedon ikoni

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy

Vertaisarvioitu
Luoma S; Sergeev P; Javarappa KKumar; Öhman TJ; Varjosalo M; Säily M; Anttila P; Sankelo M; Partanen...
Cancers2023 Julkaisujen tiedon ikoni

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy

Vertaisarvioitu
Avoin saatavuus
DOI
10.3390/cancers15092604
Luoma, Sini; Sergeev, Philipp; Javarappa, Komal Kumar; Öhman, Tiina J.; Varjosalo, Markku; Säily, Ma...
Cancers2023 Julkaisujen tiedon ikoni

Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL

DOI
10.1038/s41375-022-01725-8
Husby, Simon; Baech-Laursen, Cecilie; Eskelund, Christian W.; Favero, Francesco; Jespersen, Jakob Sc...
Leukemia2022 Julkaisujen tiedon ikoni

Impact of mobilization method and previous lenalidomide exposure in autologous stem cell transplantation

Avoin saatavuus
Partanen, Anu
Publications of the University of Eastern Finland. Dissertations in Health Sciences2019 Julkaisujen tiedon ikoni

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

Vertaisarvioitu
DOI
10.1182/blood-2016-03-704023
Albertsson-Lindblad, Alexandra; Kolstad, Arne; Laurell, Anna; Räty, Riikka; Gronbaek, Kirsten; Sundb...
Blood2016 Julkaisujen tiedon ikoni

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm:a HARMONY Alliance study

Vertaisarvioitu
DOI
10.1038/s41375-024-02360-1
Crisà, Elena; Mora, Elvira; Germing, Ulrich; Bally, Cecile; Diez Campelo, Maria; Myllymäki, Mikko; J...
Leukemia2024 Julkaisujen tiedon ikoni

Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma:a practical review

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/bjh.18295
McCaughan, Georgia J.; Gandolfi, Sara; Moore, John J.; Richardson, Paul G.
British journal of haematology2022

Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML:the HOVON-SAKK-132 trial

Vertaisarvioitu
Avoin saatavuus
DOI
10.1182/bloodadvances.2020003855
2021

RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/s00277-019-03815-7
2019

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy

Vertaisarvioitu
2023

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy

Vertaisarvioitu
2023

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy

Vertaisarvioitu
Avoin saatavuus
DOI
10.3390/cancers15092604
2023

Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL

DOI
10.1038/s41375-022-01725-8
2022

Impact of mobilization method and previous lenalidomide exposure in autologous stem cell transplantation

Avoin saatavuus
2019

Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma

Vertaisarvioitu
DOI
10.1182/blood-2016-03-704023
2016

Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm:a HARMONY Alliance study

Vertaisarvioitu
DOI
10.1038/s41375-024-02360-1
2024

Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma:a practical review

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/bjh.18295
2022